Pharmacists' perspectives on school stock inhaler access for children

J Public Health Policy. 2023 Sep;44(3):464-476. doi: 10.1057/s41271-023-00423-8. Epub 2023 Jun 21.

Abstract

Several states in the United States (U.S.) have laws permitting stock inhalers, including short-acting beta-agonist inhalers, such as albuterol, and spacers to be prescribed to, dispensed to, and stocked in schools for use in students in respiratory distress, based on a protocol. This survey study assessed Arizona pharmacists' (1) levels of comfort for dispensing a short-acting beta-agonist inhaler to an individual child versus a stock inhaler to a school, and (2) awareness of the related Arizona state law. Researchers surveyed pharmacists licensed in Arizona who self-reported practicing in an outpatient pharmacy setting. Among 251 pharmacist participants, 62% practiced in a chain community pharmacy. About 80.8% felt comfortable filling a prescription for an albuterol inhaler in a pediatric patient case, whereas only 26.7% felt comfortable filling a prescription for albuterol inhalers to be used as stock inhalers for a given school. Among those who would not fill the stock inhaler prescription, only 5.5% reported awareness of the state law compared to 42.6% of those who would fill it (p < 0.0001). This survey identified a lack of pharmacist awareness of state laws pertaining to stock inhalers for schools.

Keywords: Asthma; Children; Community pharmacy; Law; School; Stock inhaler.

Publication types

  • Review

MeSH terms

  • Albuterol
  • Asthma* / drug therapy
  • Child
  • Humans
  • Nebulizers and Vaporizers
  • Pharmacists
  • Surveys and Questionnaires
  • United States

Substances

  • Albuterol